Inverse lichen planus post Oxford‐AstraZeneca COVID‐19 vaccine

Awada, Bassem; Abdullah, Lina; Kurban, Mazen; Abbas, Ossama

doi:10.1111/jocd.14738

Cited by 13 publications

(18 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…RCM, reflectance confocal microscopy few cases of new-onset LP related to COVID-19 vaccination (Table 1). [5][6][7][8][9][10] Clinical trials showed that the vaccination elicits a Thelper 1 (Th1) response, increasing the serum levels of Interleukin 2, Tumor Necrosis Factor-α and Interferon-c. 11 These cytokines may cause new-onset LP development since they are involved also in the pathogenesis of this disease. 11 Several treatments and several diseases changed during COVID-19 pandemic period.…”

mentioning

confidence: 99%

New‐onset lichen planus arising after COVID‐19 vaccination

Zagaria

Villani

Ruggiero

et al. 2022

Dermatologic Therapy

View full text Add to dashboard Cite

Dear Editor, COVID-19 pandemic vaccination campaign is the main weapon to overcome this global emergency. Several cutaneous reactions related to COVID-19 vaccination have been reported. 1,2 Herein, we report the case of a 54 year-old male patient referring at our outpatient clinic for widespread pruritic lesions appeared 10 days after the first dose of Pfizer mRNABNT162b2 vaccine. Dermatological examination revealed small, polygonal, erythematous pap-

show abstract

mentioning

confidence: 99%

New‐onset lichen planus arising after COVID‐19 vaccination

Zagaria

Villani

Ruggiero

et al. 2022

Dermatologic Therapy

View full text Add to dashboard Cite

show abstract

“…61 To date, 13 cases of new-onset cutaneous lichen planus and 3 cases of cutaneous lichen planus exacerbation have been reported. [62][63][64][65][66][67][68][69][70][71][72][73][74][75][76] Like psoriasis, also cases of new onset and flare of atopic dermatitis or eczema have been reported (7 and 14, respectively). [77][78][79][80][81][82][83] However, there is not a clear correlation with clinical phenotypes.…”

Section: Resultsmentioning

confidence: 99%

“… BNT162b2: 10 mRNA-1273: 3 AZD1222: 3 Ad26.COV2: 1 Flare of psoriasis 81 Huang et al 29 (15), Sotiriou et al 30 (14), Koumaki et al 31 (12), Megna et al 32 (11), Wei et al 53 (6), Ruggiero et al 26 (4), Durmaz et al 33 (2), Tran et al 34 (2), Piccolo et al 36 (2), Bostan et al 37 (1), Nagrani et al 35 (1), Pavia et al 38 (1), Durmus et al 39 (1), Fang et al 40 (1), Krajewski et al 41 (1), Trepanowski et al 42 (1), Mieczkowska et al 43 (1), Lopez et al 44 (1), Perna et al 45 (1), Tsunoda et al 47 (1), Nia et al 48 (1), Pesqué et al 28 (1). BNT162b2: 43 mRNA-1273: 17 AZD1222: 21 Ad26.COV2: 0 Cutaneous lichen planus 16 New-onset: Merhy et al 62 (1), Camela et al 63 (1), Kato et al 69 (1), Diab et al 70 (1), Zagaria et al 71 (1), Awada et al 72 (1), Picone et al 73 (1), Hlaca et al 74 (1), Zengarini et al 75 (1), Masseran et al 76 (1), Gamonal et al 64 (1), Alrawashdeh et al 65 (1), Shakoei et al 66 (1). Flare: Hiltun et al 67 (1), Herzum et al 68 (1), Hlaca et al 74 (1).…”

Section: Methodsmentioning

confidence: 99%

“…(1). Merhy et al62 (1), Camela et al63 (1), Kato et al69 (1), Diab et al70 (1), Zagaria et al71 (1), Awada et al72 (1), Picone et al73 (1), Hlaca et al74 (1), Zengarini et al75 (1), Masseran et al76 (1), Gamonal et al64 (1), Alrawashdeh et al65 (1), Shakoei et al66 (1). Zou et al122 (3), Gui et al123 (2), Rouatbi et al124 (2), Aryanian et al125 (1), Koutlas et al126 (1), Knechtl et al127 (1), Ong et al128 (1), Yıldırıcı et al129 (1), Singh et al130 (1), Norimatsu et al131 (1), Agharbi et al132 (1), Almasi-Nasrabadi et al133 (1),…”

mentioning

confidence: 99%

See 1 more Smart Citation

Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature

Battista¹,

Marasca²,

Genco³

et al. 2022

CCID

View full text Add to dashboard Cite

The outbreak of coronavirus disease 2019 represented a new worldwide challenge, strongly impacting on the global economy, overall health and lifestyle. Since then, several strategies have been adopted to contain the widespread of infection. Among these, vaccination is currently the most important measure to fight against the pandemic. However, several concerns such as slower-than-hoped-for rollout, the hurried approval with limited data, the mechanism of action (in particular mRNA-based), and the uncertain duration of protection they afforded were initially raised. Moreover, even if cutaneous reactions have been rarely reported in clinical trials, global mass vaccination showed several dermatologic reactions not initially recognized, leaving dermatologists to decide how to diagnose and treat them. In this scenario, dermatologists should be ready to promptly recognize these clinical manifestations. Thus, the aim of this manuscript is to review current literature on cutaneous reactions following COVID-19 vaccination, particularly inflammatory dermatological diseases, in order to help clinicians to better understand these dermatological conditions and to provide an extensive overview of all the vaccine-related skin manifestations.

show abstract

“…F [ 20 ] (Kulkarni and Sollecito) Vaccination Unspecified “Immediately following the administration” (flare) Left buccal mucosa Unspecified Regressed to baseline after 3 weeks 44-y.o. M [ 21 ] (Awada et al) Vaccination Vaxzevria, 2nd dose 14 days Axillae Betamethasone cream once daily Resolution after 4 weeks 65-y.o. F [ 22 ] (Masseran et al) Vaccination Vaxzevria, 1st and 2nd doses 10 days (1st dose), 7 days (2nd dose) Arms, legs, buttocks, and abdomen Clobetasol propionate 0.05% cream Near-complete remission in 4 weeks with residual pruritus and pigmentation 35-y.o.…”

Section: Appendixmentioning

confidence: 99%

Lichen planus after COVID-19 infection and vaccination

Zou

Daveluy

2022

Arch Dermatol Res

View full text Add to dashboard Cite

Lichen planus (LP) is an inflammatory disorder believed to result from CD8 + cytotoxic T -cell (CTL)-mediated autoimmune reactions against basal keratinocytes. We present a review of LP following COVID-19 infection and vaccination. Literature searches were conducted on PubMed and Google Scholar from 2019 to 7/2022. 36 articles were selected based on subject relevance, and references within articles were also screened. 39 cases of post-vaccination LP and 6 cases of post-infection LP were found among case reports and case series. 152 cases of post-vaccination LP and 12 cases of post-infection LP were found in retrospective and prospective studies. LP is a rare complication of COVID-19 infection and vaccination that may be mediated by overstimulation of T -cell responses and proinflammatory cytokine production. However, it does not represent a limitation against COVID-19 vaccination, and the benefits of vaccination considerably outweigh the risks.

show abstract

Inverse lichen planus post Oxford‐AstraZeneca COVID‐19 vaccine

Cited by 13 publications

References 10 publications

New‐onset lichen planus arising after COVID‐19 vaccination

New‐onset lichen planus arising after COVID‐19 vaccination

Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature

Lichen planus after COVID-19 infection and vaccination

Contact Info

Product

Resources

About